About Edward Gomperts
Form D filings for Hillhurst Biopharmaceuticals in 2023 list Edward Gomperts as executive officer and director.
Edward Gomperts first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Edward Gomperts in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Edward Gomperts works with at each company, as listed on that company's latest Form D.
Hillhurst Biopharmaceuticals, Inc. · Form D, Sep 26, 2023
JF
Jeff Friedman
Director
AG
Andrew Gomperts
Chief Executive Officer and director